Asthma, COPD tied to worse COVID-19 outcomes

Asthma, COPD tied to worse COVID-19 outcomes

(HealthDay)—Patients with active asthma or chronic obstructive pulmonary disease (COPD) are at increased risk for severe COVID-19 outcomes, according to a study published online Aug. 10 in the Journal of Allergy and Clinical Immunology: In Practice.

Brian Z. Huang, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues assessed asthma disease status and COPD in relation to COVID-19 severity. The analysis included electronic medical records data from 61,338 diagnosed with COVID-19 in a large, diverse integrated health care system.

The researchers found that patients with active asthma had increased odds of hospitalization, intensive respiratory support, and intensive care unit admission (odds ratios, 1.66, 1.49, and 1.47, respectively) versus patients without asthma or COPD. Among patients with inactive asthma, no increased risks were seen. COPD was associated with increased risks for hospitalization (odds ratio, 1.27), intensive respiratory support (odds ratio, 1.49), and mortality (hazard ratio, 1.67). Use of asthma medications among active asthma patients was associated with more than 25 percent lower odds for COVID-19 outcomes versus patients without medication.

"These findings suggest that patients, especially those who require , should continue taking control medications during the COVID-19 pandemic," the authors write.


Explore further

People who manage their asthma can improve their chances against COVID-19

More information: Abstract/Full Text

Copyright © 2021 HealthDay. All rights reserved.

Citation: Asthma, COPD tied to worse COVID-19 outcomes (2021, September 2) retrieved 25 October 2021 from https://medicalxpress.com/news/2021-09-asthma-copd-tied-worse-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors